Genuine compassion and focus on the individual needs of their patients are the hallmarks of Regional Cancer Care Associates’ uniquely personal approach to cancer care, delivered close to home in communities across New Jersey.
This year, 16 doctors from Regional Cancer Care Associates, or RCCA, were recognized for having these attributes and other distinctive traits when they were named Top Cancer Doctors as selected by health care research and information company Castle Connolly. The company has built a long-standing reputation as America’s trusted source for identifying top doctors through its exhaustive and independent process of peer nomination, research, review and screening.
By trusting Regional Cancer Care Associates, with 17 locations across New Jersey, you’ll benefit from state-of-the-art multidisciplinary care in a supportive, hopeful environment — conveniently close to home. What’s more, a study in the Journal of Clinical Oncology showed that receiving cancer care close to home reduces hospitalizations. Having easy access to family and friends is an important source of strength when focusing on healing
The 16 RCCA physicians named to Castle Connolly’s prestigious list of 2022 Top Cancer Doctors in New Jersey are:
Of the more than 850,000 practicing physicians in the U.S., just 7% are named to the Top Doctors list. The designation is conferred only after a rigorous vetting process conducted by an experienced medical review board. Reviewers consider each doctors’ skills, professionalism, training/qualifications, experience, competence, outcomes and achievements as well as his or her relational skills and empathy toward patients.
RCCA has 90-plus cancer specialists who treat patients at more than 20 RCCA care centers in New Jersey, Connecticut, Maryland and the Washington, D.C., area. Those oncologists see more than 23,000 new patients each year and provide care to more than 225,000 established patients, collaborating closely with their patients’ other physicians.
RCCA is the top choice of many patients due to the comprehensive services offered by its physicians, including the latest in cutting-edge treatments, including immunotherapies and targeted therapy, as well as access to a wide range of clinical trials. In addition to serving patients who have solid tumors, blood-based cancers, and benign blood disorders such as anemia, RCCA care centers also provide infusion services to people with a number of non-oncologic conditions—including multiple sclerosis, Crohn’s disease, asthma, and rheumatoid arthritis — who take intravenously-administered medications.
To learn more about RCCA, call 844-928-0089 or visit RCCA.com.
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Black Americans with lung cancer are 18% less likely than white people to be diagnosed in the early stages of the disease, 23% less likely to receive surgery, and 21% less likely to survive 5 years after diagnosis, according to the American Lung Association.
Cancer can affect anyone from any background. However, some racial and ethnic groups have higher rates of certain kinds of cancer. Regional Cancer Care Associates
Infusion therapy is a treatment modality that administers medications intravenously. While most people associate infusions with cancer treatment, several different conditions can be managed and
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.
